de la Cruz Maxine, Yennu Sriram, Liu Diane, Wu Jimin, Reddy Akhila, Bruera Eduardo
1 Department of Palliative Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center , Houston, Texas.
2 Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, Texas.
J Palliat Med. 2017 Jun;20(6):638-641. doi: 10.1089/jpm.2016.0315. Epub 2017 Feb 3.
Delirium is the most common neuropsychiatric condition in very ill patients and those at the end of life. Previous case reports found that delirium-induced disinhibition may lead to overexpression of symptoms. It negatively affects communication between patients, family members, and the medical team and can sometimes lead to inappropriate interventions. Better understanding would result in improved care. Our aim was to determine the effect of delirium on the reporting of symptom severity in patients with advanced cancer.
We reviewed 329 consecutive patients admitted to the acute palliative care unit (APCU) without a diagnosis of delirium from January to December 2011. Demographics, Memorial Delirium Assessment Scale, Eastern Cooperative Oncology Group (ECOG) Performance status, and Edmonton Symptom Assessment Scale (ESAS) on two time points were collected. The first time point was on admission and the second time point for group A was day one (+two days) of delirium. For group B, the second time point was within two to four days before discharge from the APCU. Patients who developed delirium and those who did not develop delirium during the entire course of admission were compared using chi-squared test and Wilcoxon rank-sum test. Paired t-test was used to assess if the change of ESAS from baseline to follow-up was associated with delirium.
Ninety-six of 329 (29%) patients developed delirium during their admission to the APCU. The median time to delirium was two days. There was no difference in the length of stay in the APCU for both groups. Patients who did not have delirium expressed improvement in all their symptoms, while those who developed delirium during hospitalization showed no improvement in physical symptoms and worsening in depression, anxiety, appetite, and well-being.
Patients with delirium reported no improvement or worsening symptoms compared to patients without delirium. Screening for delirium is important in patients who continue to report worsening symptoms despite appropriate management.
谵妄是重症患者和临终患者中最常见的神经精神疾病。既往病例报告发现,谵妄所致的行为脱抑制可能导致症状过度表现。它对患者、家属和医疗团队之间的沟通产生负面影响,有时还会导致不适当的干预措施。更好地了解谵妄将有助于改善护理。我们的目的是确定谵妄对晚期癌症患者症状严重程度报告的影响。
我们回顾了2011年1月至12月连续入住急性姑息治疗病房(APCU)且未诊断为谵妄的329例患者。收集了患者的人口统计学资料、纪念谵妄评估量表、东部肿瘤协作组(ECOG)体能状态以及两个时间点的埃德蒙顿症状评估量表(ESAS)。第一个时间点是入院时,A组的第二个时间点是谵妄发生的第一天(+两天)。对于B组,第二个时间点是在从APCU出院前的两到四天内。使用卡方检验和Wilcoxon秩和检验比较了在整个住院期间发生谵妄的患者和未发生谵妄的患者。采用配对t检验评估ESAS从基线到随访的变化是否与谵妄有关。
329例患者中有96例(29%)在入住APCU期间发生谵妄。谵妄发生的中位时间为两天。两组在APCU的住院时间没有差异。未发生谵妄的患者所有症状均有改善,而住院期间发生谵妄的患者身体症状没有改善,抑郁、焦虑、食欲和幸福感则有所恶化。
与未发生谵妄的患者相比,发生谵妄的患者报告症状没有改善或有所恶化。对于尽管进行了适当管理但仍持续报告症状恶化的患者,筛查谵妄很重要。